Skip to main content

Table 1 Patient characteristics

From: Interleukin-10 gene down-expression in circulating mononuclear cells during infusion of drotrecogin-α activated: a pilot study

 

DAA +

(n= 16)

DAA -

(n= 16)

P

Age (yr)

67.4 ρ 4.0

67.9 ρ 2.7

NS

SAPS II

62.7 ± 2.8

61.5 ± 3.7

NS

LOD score

9.3 ± 0.8

8.4 ± 0.8

NS

Septicaemia (n (%))

9 (56%)

11 (69%)

NS

ICU stay (days)

32.9 ± 8.8

54.2 ± 19.3

NS

Mortality at Day 28 (n (%))

7 (43%)

8 (50%)

NS

Type of bacterium : n (%)

   

   Gram-positive

8 (50%)

6 (37%)

 

   Gram-negative

5 (31%)

6 (37%)

NS

   Others (fungi)

3 (19%)

6 (37%)

 

Source of infection : n (%)

   

   Pneumonia

6 (37%)

9 (56%)

 

   Peritonitis

5 (31%)

2 (12.5%)

NS

   Others

5 (31%)

4 (25%)

 

Toll-like receptors genotyping: n

   

Genotype of TLR-2 (Arg753Arg/Arg753Gln/Gln753Gln)

16/0/0

16/0/0

NS

Genotype of TLR-4 (Asp299Asp/Asp299Gly/Gly299Gly)

12/4/0

15/1/0

NS

Genotype of TLR-4

(Thr399Thr/Thr399Ile/Ile399Ile)

12/4/0

15/1/0

NS

  1. Data are means +/- SD. The respective P values result from the non-parametric Kruskal-Wallis test, while associations with the genotype were searched with logistic regression. SAPS II, Simplified Acute Physiology Score II on admission; LOD score, Logistic Organ Dysfunction score; TLRs, Toll like receptors; NS, non-significant.